# Nasal Septum Perforation Treatment Using Tissue Engineered Cartilage Graft

> **NCT04633928** · PHASE1 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 5 (actual)

## Conditions studied

- Nasal Cartilage Septum Perforations

## Interventions

- **BIOLOGICAL:** N-TEC: Autologous nasal chondrocytes and ECM proteins

## Key facts

- **NCT ID:** NCT04633928
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-09
- **Primary completion:** 2023-04-24
- **Final completion:** 2023-04-24
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04633928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04633928, "Nasal Septum Perforation Treatment Using Tissue Engineered Cartilage Graft". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04633928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*